Search results
Moderna to Present at Upcoming Conferences in May/June 2024
The Joplin Globe· 2 days agoA replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation. Moderna is a leader in the creation of the ...
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Investopedia· 5 days agoModerna (MRNA) shares lost ground in intraday trading Friday as the biotech’s effort to move beyond...
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 2 hours agoToday, Pfizer and Moderna dominate the coronavirus vaccine market, making it difficult for a smaller player to gain much share, but an alliance with a...
Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot
Bloomberg· 6 days agoThe biotech’s lackluster new RSV vaccine undercuts the promise of mRNA to revolutionize health care....
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 5 days ago, opens new tab respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoThe Food and Drug Administration (FDA) notified Moderna Inc MRNA on Friday that its review of a new vaccine has been delayed. The agency, citing administrative constraints ...
Stock Market News for May 14, 2024
Zacks via Yahoo Finance· 23 hours agoThe tech-heavy Nasdaq gained 47.37 points or 0.3% to close at 16,388.24. The major gainer of the Nasdaq Composite was Moderna, Inc. MRNA, after jumping...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 5 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
Metis Global Partners LLC Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days agoMetis Global Partners LLC reduced its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.9% during the fourth quarter, according to the company in its most ...
Moderna says FDA delaying decision on RSV vaccine approval
Stars and Stripes· 5 days agoUS regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to...